References
- Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis. 2009 May;13(3):380–386.10.1016/j.ijid.2008.07.021
- Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I, et al. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2012;12(9):805–811.10.1089/vbz.2011.0896
- Leblebicioglu H. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents. 2010;36 Suppl 1:S43–S46.10.1016/j.ijantimicag.2010.06.020
- Sunbul M, Leblebicioglu H, Fletcher TE, Elaldi N, Ozkurt Z, Bastug A, et al. Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J Infect. 2015;71(5):597–599. doi:10.1016/j.jinf.2015.07.003.
- Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo haemorrhagic fever outbreak in middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54(4):385–389.10.1099/jmm.0.45865-0
- Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006;52(3):207–215.10.1016/j.jinf.2005.05.003
- Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012;49(2):105–110.
- Bakır M, Gözel MG, Köksal I, Aşık Z, Günal Ö, Yılmaz H, et al. Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF). Eur J Clin Microbiol Infect Dis. 2015;34(2):325–330.10.1007/s10096-014-2238-0
- Dokuzoguz B, Celikbas AK, Gök ŞE, Baykam N, Eroglu MN, Ergonul Ö. Severity scoring ındex for Crimean-Congo hemorrhagic fever and the ımpact of ribavirin and corticosteroids on fatality. Clin Infect Dis. 2013 Nov;57(9):1270–1274.10.1093/cid/cit527
- Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect. 2009 Mar;58(3):238–244.10.1016/j.jinf.2009.01.014
- Gozel MG, Dokmetas I, Oztop AY, Engin A, Elaldi N, Bakir M. Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus. Int J Infect Dis. 2013 Nov;17(11):e1046–e1050.10.1016/j.ijid.2013.05.005
- Mardani M, Rahnavardi M, Rajaeinejad M, Naini KH, Chinikar S, Pourmalek F, et al. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007;76(3):443–445. PubMed PMID: 17360865.
- Sisman A. Epidemiologic features and risk factors of Crimean-Congo hemorrhagic fever in Samsun province. Turkey. J Epidemiol. 2013;23(2):95–102.10.2188/jea.JE20120097
- Hekimoglu HC, Demirci NA. Evaluation of cases with a preliminary diagnosis of Crimean-Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey. Afr Health Sci. 2014;14(4):873–881.
- Hosoglu S, Geyik MF, Akalin S, Ayaz C, Kokoglu OF, Loeb M. A simple validated prediction rule to diagnose typhoid fever in Turkey. Trans R Soc Trop Med Hyg. 2006;100:1068–1074.10.1016/j.trstmh.2005.12.007
- Tabak YP, Johannes RS, Silber JH. Using automated clinical data for risk adjustment. Med Care. 2007;45:789–805.10.1097/MLR.0b013e31803d3b41
- Escobar GJ, Greene JD, Scheirer P, Gardner MN, Draper D, Kipnis P. Risk-adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases. Med Care. 2008;46:232–239.10.1097/MLR.0b013e3181589bb6